Clinical effect analysis of vertebroplasty with high viscosity and standard bone cement for Kummell disease

Jian Wang,Jianxin Zhang,Jianbiao Huang,Jie Chen,Qunwei Dong,Hui Zhu,Xusheng Huang,Jianxian Luo

DOI: https://doi.org/10.1097/md.0000000000039960

IF: 1.6

2024-10-09

Medicine

Abstract:Patients with Kummell disease usually have back pain resulting from minor trauma or no apparent cause on a background of osteoporosis. After an asymptomatic period lasting several weeks or months, pain recurs at the original site and progressively worsens, with severe cases developing progressive spinal kyphosis. Dr Hermann Kummell first reported the condition in 1895. [ 1 ] Kummell disease is more common in women, with an incidence of approximately 3.5% in those aged 50 to 54 years, rising to 16.6% at age 80. Imaging studies reveal collapsed vertebrae with linear, transverse, or crescent-shaped radiolucent shadows, known as the "intravertebral vacuum cleft" (IVC). [ 2 ] Advances in imaging technology have made MRI the most effective tool for diagnosing IVC, confirming that Kummell disease is not rare. [ 3 ] Studies show that due to varying gas and liquid content within the IVC, affected vertebrae exhibit low signal intensity on T1-weighted MRI and variable signals on T2-weighted MRI. [ 4 ] Currently, percutaneous vertebroplasty (PVP) has been established as an safe and effective surgery for treating Kummell disease, with notable advantages such as minimal invasiveness, rapid recovery, and good therapeutic effects. However, local fissures surrounding the intravertebral clefts in Kummell disease can lead to cement leakage when using standard bone cement, causing incomplete diffusion and suboptimal surgical outcomes. To mitigate these risks, our research team employed high-viscosity bone cement for injection into the affected vertebral clefts, resulting in significant clinical improvements.

medicine, general & internal